Congratulations to three Division of Diabetes, Endocrinology and Metabolism clinical faculty for their recent promotions: Shichun Bao, MD, PhD, Professor of Medicine; Gitanjali Srivastava, MD, Professor of Medicine, Pediatrics, and Surgery; and Lindsay A. Bischoff, MD, Professor of Medicine.
Alvin Powers, MD (Diabetes, Endocrinology and Metabolism), last week received the American Diabetes Association's (ADA) 2024 Albert Renold Award at the ADA's 84th Scientific Session in Orlando.
The award recognizes an individual who has made outstanding contributions to the training and mentorship of diabetes research scientists.
In a study co-led by Ray Blind, PhD (Diabetes, Endocrinology and Metabolism), and colleagues at VUMC and the Sanford Burnham Prebys Discovery Institute, researchers have connected the Hippo pathway to phosphoinositides, a particular type of lipid, or fat molecule, which regulates cell functions that are critical in cancer, obesity and diabetes. The findings were recently published in Science Signaling.
The Vanderbilt Diabetes Research and Training Center (DRTC) recently hosted its annual Diabetes Day, where they highlighted recent advancements in the field and recognized young investigators for their research efforts. One of 17 diabetes research centers in the United States, the Vanderbilt DRTC today is comprised of 140 faculty members from 15 departments and three colleges or schools at Vanderbilt and Meharry Medical College who conduct basic, clinical and translational research on the cause, prevention, treatment and complications of diabetes and obesity.
Vanderbilt University School of Medicine continues to make impressive strides in research funding, rankings and faculty accomplishments, Dean Jeff Balser, MD, PhD, said Friday during the spring faculty meeting.
Research has confirmed that women who undergo menopause before age 45 are at an increased risk of heart failure, cardiovascular disease and other conditions. Now, a link has recently been reported between late menopause and heart failure – with an important role for obesity.
In a collaborative effort co-led by teams from Vanderbilt University Medical Center (VUMC) and the University of Michigan, a comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes.
Alvin C. Powers, MD, Joe C. Davis Professor of Biomedical Science and professor of Medicine, Molecular Physiology and Biophysics, has received the 2023 William S. Middleton Award, the highest honor awarded by the Department of Veterans Affairs (VA) Biomedical Laboratory Research and Development Service.
A team of surgeons and biomedical engineers at Vanderbilt University Medical Center and Vanderbilt University (VU) have shown the use of probe-based near infrared autofluorescence (NIRAF) technology helps confirm the identification of parathyroid glands during endocrine surgery, and their findings are part of a multisite trial of the technology now underway.
A multisite, international phase 2 trial evaluating the investigational drug garetosmab has shown that it reduced soft-tissue flare-ups significantly and prevented new areas of abnormal bone formation in patients with fibrodysplasia ossificans progressiva (FOP).
